Article R5121-114
…d at the time of inspection by customs officers.For imported medicinal products required for biomedical research, a document drawn up by the Agence nationale de sécurité du médicament et des produits…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 4061–4070 of 10604 articles for “Art. CA Paris 24-10-2024”
…d at the time of inspection by customs officers.For imported medicinal products required for biomedical research, a document drawn up by the Agence nationale de sécurité du médicament et des produits…
…e quantitative and qualitative composition in terms of active substances and excipients, pharmaceutical form and therapeutic effects are identical to those of a proprietary medicinal product which has…
…mple of the product, as it will be placed on the market, to the Agence nationale de sécurité du médicament et des produits de santé, which ensures that it complies with the marketing authorisation in…
…thorisation in France is amended by the Director General of the Agence nationale de sécurité du médicament et des produits de santé, the Director General will notify the holder of the parallel import…
…the authorisation holder notifies the Director General of the Agence nationale de sécurité du médicament et des produits de santé of the batch numbers of the authorised medicinal product being impor…
…mmary of product characteristics, with the exception of the stability period and special storage precautions, which are those provided for in the marketing authorisation obtained in the country of ori…
…o an export authorisation issued by the Director General of the Agence nationale de sécurité du médicament et des produits de santé. III - The application for an export authorisation must be made by a…
…le R. 5124-2, of a proprietary medicinal product benefiting from a parallel import authorisation is carried out by the holder of this authorisation, provided that he has obtained the authorisation to…
When, in application of the second paragraph of Article L. 5124-11, the Director General of the Agence nationale de sécurité du médicament et des produits de santé intends to prohibit the export of a…
…ntinued, the contractual practitioner is entitled to an indemnity intended to compensate for the precariousness of his situation. This allowance is not payable in the cases mentioned in 3° and 4° of a…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More